Delivery Order SPE2DB24D2205-SPE2DB25FDUAG

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $6.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,514.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4557444558 PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,216.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.5 mL syringes of the PEDIARIX vaccine. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award, valued at $30,241.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 0.5 ML PEDIARIX syringes, a pediatric vaccine. This is a firm-fixed-price delivery order contract with a completion date of February 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,565.80 firm fixed-price delivery order contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of December 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $12,969.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4558104811 - PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $5,724.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine, with a completion date of January 18, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,332.30 firm fixed-price delivery order contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) was issued by the Defense Logistics Agency (DLA) for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The $2,361.92 firm fixed-price contract has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $13,998.71, is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 11, 2024. Amerisourcebergen is the prime contractor, and there is no indication of any set-aside designation for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.66 firm-fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of April 10, 2024. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDUAG
    Delivery Order

This federal contract award, valued at $6,663.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 0.5 ML PEDIARIX syringes, a pediatric vaccine product, with a completion date of November 14, 2024.

The award is a Delivery Order under a broader Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. As a leading pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential medical products to various federal agencies, including the military and veterans' healthcare systems.

Generated 2/12/25, 9:26 AM